Galena Biopharma To Present At The 2013 Marcum MicroCap Conference

LAKE OSWEGO, Ore., May 23, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Rosemary Mazanet, M.D., Ph.D., Executive Vice President & Chief Medical Officer will present a corporate update at the 2013 Marcum MicroCap Conference. The presentation will take place on Thursday, May 30, 2013 at 2:00 p.m. ET at The Grand Hyatt Hotel in New York, NY.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com .
CONTACT: Remy Bernarda         Senior Director, Communications         (503) 405-8258         rbernarda@galenabiopharma.com

Galena Biopharma, Inc.

If you liked this article you might like

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

How to Dig Deep for Value in These Exuberant Markets

Value Investors Have to Go Deeper

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments